UMEM Educational Pearls - Neurology

Title: Guillain-Barre' Syndrome

Category: Neurology

Keywords: guillain-barre' syndrome, guillain-barre, gbs, polyneuropathy, peripheral neuropathy (PubMed Search)

Posted: 10/21/2009 by Aisha Liferidge, MD (Updated: 4/8/2025)
Click here to contact Aisha Liferidge, MD

 

  • Guillain-Barre’ Syndrome (GBS) is a group of immune mediated processes characterized by motor, sensory, and autonomic dysfunction of peripheral nerves.

  • Classically, GBS is an acute inflammatory demyelinating polyneuropathy (AIDP) consisting of progressive, symmetric, ascending muscle weakness and paralysis, associated with diminished deep tendon reflexes.
  • This rare condition, affecting 3,000 to 6,000 Americans annually (1 to 2 out of 100,00 per year), can lead to respiratory failure in severe cases, requiring vigilance in pro-actively administering mechanical ventilation as needed.



Title: First Time Seizures in Pregnancy

Category: Neurology

Keywords: pregnancy, seizure, epilepsy, first time seizure (PubMed Search)

Posted: 10/14/2009 by Aisha Liferidge, MD (Updated: 4/8/2025)
Click here to contact Aisha Liferidge, MD

  • Pregnant patients presenting with their first seizure, should essentially be managed in the same way as any other adult patient (i.e. Is the source of the seizure due to a reversible systemic condition, and if not, is the patient at risk for recurrent unprovoked seizures; specialist follow-up arrangement).
  • Additional pregnancy-related conditions that can be associated with seizure, such as eclampsia and cerebral venous thrombosis, should be considered.
  • While the safety of all anti-epileptic drugs in pregnancy is questionable, the use of valproate (Depakote) should definitely be avoided, given its compelling association with fetal malformations.

 



Title: MCA Strokes

Category: Neurology

Keywords: stroke, mca stroke (PubMed Search)

Posted: 10/7/2009 by Aisha Liferidge, MD (Updated: 4/8/2025)
Click here to contact Aisha Liferidge, MD

  • Strokes resulting from embolic or thrombic insult to the middle cerebral artery (MCA) are common.

 

  • These patients tend to present with contralateral motor deficit which is most pronounced in the upper extremity (and face), compared to the lower extremity.

 

  • If motor weakness is more pronounced in the lower extremity, consider an anterior cerebral artery (ACA) infarct as the source.


Title: Treatment of Refractory Status Epilepticus

Category: Neurology

Keywords: status epilepticus, seizure, phenytoin, phenobarbital, high dose phenytoin (PubMed Search)

Posted: 9/30/2009 by Aisha Liferidge, MD (Updated: 4/8/2025)
Click here to contact Aisha Liferidge, MD

  • Should patients continue to seize even after administration of a benzodiazepine (i.e. lorazepam, diazepam) plus phenytoin, additional high-dose phenytoin should first be considered.
  • While the standard loading dose for IV phenytoin is 10-20 mg/kg, it is recomended that up to 30 mg/kg of phenytoin be given for refractory status epilepticus prior to using another anti-epileptic, such as phenobarbital, pentobarbital infusion, or propofol infusion.

Show References



Title: First-time Seizures and Head CT's

Category: Neurology

Keywords: new onset seizure, head ct, seizure (PubMed Search)

Posted: 9/23/2009 by Aisha Liferidge, MD (Updated: 4/8/2025)
Click here to contact Aisha Liferidge, MD

  • Indications and timing of head CT scans in patients with a first-time seizure (FTS), who have returned to a normal baseline, are controversial.
  • The range of such patients with abnormal head CT's is broad, at 3 to 41%.
     
  • A retrospective study found that 22% of patients with a FTS and normal neurologic exams, had an abnormal head CT (Hennemen, et al).
  • Another study found that in patients with suspected alcohol withdrawal seizures, 58% had an abnormal head CT, 16% of which were clinically significant findings (Earnest, et al).
  • When feasible, neuroimaging of the brains of patients presenting with a FTS should be performed in the emergency department.  Deferred outpatient neuroimaging may be used when reliable follow-up is ensured. (Level B Recommendation).

Show References



Title: Acute Bacterial Meningitis

Category: Neurology

Keywords: meningitis, bacterial meningitis, headache, Kernig sign, Brudzinski sign (PubMed Search)

Posted: 9/16/2009 by Aisha Liferidge, MD (Updated: 4/8/2025)
Click here to contact Aisha Liferidge, MD

  • The classic triad of fever, meningismus (stiff neck), and altered mental status only occurs in 44% of cases of acute bacterial meningitis (ABM).

 

  • Headache is a much more common presenting complaint with ABM.

 

  • The sensitivity and specificity of Kernig and Brudzinski signs are suboptimal, making their presence or absence of little diagnostic value.

Show References



Title: Symptoms of Phenytoin Toxicity and Associated Levels

Category: Neurology

Keywords: phenytoin, dilantin, dilantin toxicity, ataxia, nystagmus (PubMed Search)

Posted: 9/9/2009 by Aisha Liferidge, MD (Updated: 4/8/2025)
Click here to contact Aisha Liferidge, MD

The following symptoms of phenytoin toxicity typically present initially, once plasma concentrations reach the listed levels below:

  • Nystagmus (on lateral gaze, at 20 mcg/mL)
  • Ataxia (at 30 mcg/mL)
  • Dysarthria and lethargy (at over 40 mcg/mL)


Other associated symptoms include tremor, hyper-reflexia, nausea, and vomiting.



Title: Phenytoin and Phenobarbital Toxicity

Category: Neurology

Keywords: phenytoin, phenbarbital, dilantin (PubMed Search)

Posted: 9/2/2009 by Aisha Liferidge, MD (Updated: 4/8/2025)
Click here to contact Aisha Liferidge, MD

 

  • The therapeutic ranges for phenytoin (dilantin) and phenobarbital in adults are 10 to 20 mcg/mL and 10 to 30 mcg/mL, respectively.
  • Phenytoin plasma levels rise more rapidly than phenobarbital levels; therefore, an acute overdose of the two together will likely manifest as phenytoin toxicity before phenobarbital toxicity.
  • Phenytoin has a more narrow margin between therapeutic and toxic levels than does phenobarbital.


Title: First-time Seizures: Labs to Check

Category: Neurology

Keywords: seizure, first-time seizure, new onset seizure (PubMed Search)

Posted: 8/26/2009 by Aisha Liferidge, MD (Updated: 4/8/2025)
Click here to contact Aisha Liferidge, MD

  • Glucose abnormalities and hyponatremia are the two laboratory findings most frequently associated with triggering first-time seizures in adult patients.
  • Always check an HCG in women who present with their first seizure, as this may reveal the source (i.e. eclampsia) and/or may affect testing, disposition, and initiation of an anti-epileptic drug (AED).
  • Drug abuse screens should be considered in patients with their first seizure, but no prospective studies have demonstrated benefit from routine use.

Show References



Title: Altered Level of Consciousness Pearl

Category: Neurology

Keywords: correction to altered level of consciousness pearl (PubMed Search)

Posted: 8/20/2009 by Aisha Liferidge, MD (Updated: 8/22/2009)
Click here to contact Aisha Liferidge, MD

  • To be conscious, one must be both awake and alert.
  • Patients who sustain severe anoxic cortical damage, with brainstem sparing, exhibit wakefulness and sleep, but are not aware, and thus, are unconscious.
  • This description is the hallmark of a "vegetative state."
  • A coma is a deep depression in the state of altered level of consciousness, which is characterized by the patient's response to verbal or painful stimuli.


Title: Signs and Symptoms of Dysarthria

Category: Neurology

Keywords: dysarthria, stroke (PubMed Search)

Posted: 8/12/2009 by Aisha Liferidge, MD (Updated: 4/8/2025)
Click here to contact Aisha Liferidge, MD

Depending on the location of infarct, stroke patients with dysarthria (a motor speech disorder) may exhibit the following signs and symptoms:

  • "Slurred" speech
  • Speaking softly or barely able to whisper
  • Slow rate of speech
  • Rapid rate of speech with a "mumbling" quality
  • Limited tongue, lip, and jaw movement
  • Abnormal intonation (rhythm) when speaking
  • Changes in vocal quality ("nasal" speech or sounding "stuffy")
  • Hoarseness
  • Breathiness
  • Drooling or poor control of saliva
  • Chewing and swallowing difficulty


Title: Progressive Multifocal Leukoencephalopathy (PML)

Category: Neurology

Keywords: pml, progressive multifocal leukoencephalopathy, HIV, AIDS, opportunistic infections, demyelinating diseases (PubMed Search)

Posted: 8/5/2009 by Aisha Liferidge, MD (Updated: 4/8/2025)
Click here to contact Aisha Liferidge, MD

  • Progressive Multifocal Leukoencephalopathy (PML) is a life-threatening demyelinating condition that results from the reactivation of the polyomavirus JC. It primarily affects the immunocompromised (most commonly individuals with CD4 counts of < 200).
  • Prior to the advent and widespread use of anti-retroviral therapy, 1 to 5% of those with AIDS developed PML.  HAART is now considered a mainstay of treatment, along with cessation of immunosupressant therapies.
  • PML lesions typically occur bilaterally in the peri-ventricular white matter portions of the brain and do not conform to specific cerebrovascular territories
  • Non-contrast CT and MRI may reveal PML lesions, but definitive diagnosis is made via brain biopsy
  • Symptoms of PML include subacute neurologic deficits such as:  mental status abnormality, gait ataxia, limb ataxia, hemiparesis, monoparesis, and visual abnormalities such as diplopia and hemianopia.  Seizure occurs in up to 18% of cases.   


Title: Lidocaine Toxicity

Category: Neurology

Keywords: lidocaine, lidocaine toxicity, seizure (PubMed Search)

Posted: 7/30/2009 by Aisha Liferidge, MD (Updated: 4/8/2025)
Click here to contact Aisha Liferidge, MD

  • Lidocaine toxicity typically manifests as central nervous system symptoms such as tongue numbness, tinnitus, visual disturbances, seizure, and cardiovascular depression.
  • The maximum dose of lidocaine without epinephrine is 5 mg/kg (4.5 mg/kg, to be exact) and 7 mg/kg for lidocaine with epinephrine.  The total maxiumum dose is 300 mg.


Title: Dyspaghia and Stroke

Category: Neurology

Keywords: dysphagia, stroke, dysarthria, gag reflex (PubMed Search)

Posted: 7/22/2009 by Aisha Liferidge, MD (Updated: 4/8/2025)
Click here to contact Aisha Liferidge, MD

  • During the emergency department management of all stroke patients, an NPO (nothing by mouth) status should be maintained until a formal swallow study can be performed to determine whether there is dysphagia.
  • The best predictor of dysphagia (swallowing difficulty) in a stroke patient is the presence of dysarthria (motor speech abnormality).
  • While the absence of a gag reflex, may suggest some degree of dysphagia, remember that about 10 to 15% of people lack a gag reflex.


Title: Recognizing Dysarthria

Category: Neurology

Keywords: dysarthria, apraxia, lacunar infarcts, pure dysarthria (PubMed Search)

Posted: 7/15/2009 by Aisha Liferidge, MD (Updated: 4/8/2025)
Click here to contact Aisha Liferidge, MD

  • Dysarthria is a motor speech abnormality that commonly results from stroke and is related to focal muscular deficits in the face.
  • One of the most challenging aspects of recognizing dysarthria relates to distinguishing it from apraxia. 
  • Apraxia has nothing to do with a focal motor deficit, but rather a cortical deficit which results in an inability to optimally execute the function of the facial musculature.
  • Isolated dysarthria without other neurologic deficit, termed pure dysarthria, is rare and thought to result from multiple lacunar infarcts causing hypoperfusion of the frontal cortex.

Show References



Title: Olfactory Nerve Injury in Head Trauma

Category: Neurology

Keywords: cranial nerve I, olfactory nerve, hyposmia, anosmia, head injury, head trauma (PubMed Search)

Posted: 7/8/2009 by Aisha Liferidge, MD
Click here to contact Aisha Liferidge, MD

  • While most typically only test and document that "cranial nerves II - XII are intact" when examining a patient, I would argue that cranial nerve I should also be tested in all head injury cases wherein there was significant facial/nasal trauma
  • Direct blows to the face, by way of airbag deployment, dash board trauma, or assault, for example, can easily cause the ethmoid bone (see image below) to fracture leaving the olfactory nerve exposed to potential trauma as it crosses the cribiform plate.
  • Shearing of this nerve can cause irreversible anosmia or hyposmia (inability or decreased ability to smell, respectively).
  • The easiest, most effective way to test cranial nerve I is one nostril at a time (occlude the one not being tested), using items such as coffee, peppermint oil, or cloves.  More annoying smells like that of an alcohol prep or benzoin, can also be used and would likely be more readily accessible in an emergency department.



Title: Xanthochromia in CSF

Category: Neurology

Keywords: xanthochromia, csf, lumbar puncture, meningitis, subarachnoid hemorrhage, intracranial bleed (PubMed Search)

Posted: 7/2/2009 by Aisha Liferidge, MD (Updated: 4/8/2025)
Click here to contact Aisha Liferidge, MD

  • Xanthochromia is the yellowish discoloration of the supernatant from centrifuged cerebrospinal fluid (CSF).
  • Xanthochromia is an abnormal finding and results from the lysis of red blood cells.
  • Xanthochromia is present is CSF in > 90% of patients within 12 hours of subarachnoid hemorrhage (SAH) onset.




Title: Assessing Opening Pressure During Lumbar Puncture

Category: Neurology

Keywords: opening pressure, csf, cerebrospinal fluid, elevated opening pressure, lumbar puncture (PubMed Search)

Posted: 6/24/2009 by Aisha Liferidge, MD (Updated: 4/8/2025)
Click here to contact Aisha Liferidge, MD

  • Several conditions cause increased intracranial pressure (ICP), requiring lumbar puncture (LP) with opening pressure (OP) measurement for diagnostic and therapeutic management.
  • Examples of such include:  pseudotumor cerebri, (cryptococcal) meningitis, intracranial mass, and intracranial hemorrhage.
  • In order to ensure an accurate measurement, OP should be assessed while the patient is in the lateral decubitus position with the neck and legs in a neutral position.
  • Normal OP ranges from 10 to 100 mm H20 in children, 60 to 200 mm H20 after age 8, and up to 250 mm H20 in the obese.  OP > 250 = intracranial hypertension.
  • OP (the meniscus level) can fluctuate by 2 to 5 mm H20 with patient's pulse and by 4 to 10 mm H20 with patient's respirations.
  • A patient's symptoms of headache and/or neurologic deficit is often relieved by lowering the ICP through slow removal of CSF during LP.  The pressure level should not be lowered by any more than 50% of the initial OP.

Show References



Title: ABCD Rule to Predict Short-term Stroke Risk After TIA

Category: Neurology

Keywords: tia, stroke, abcd rule, clinical prediction rule (PubMed Search)

Posted: 6/17/2009 by Aisha Liferidge, MD
Click here to contact Aisha Liferidge, MD

  • 5 to 10% of TIA victims go on to have a complete stroke within 7 days.
  • The following validated ABCD clinical prediction rule can be used to risk stratify your next TIA patient in determining who requires an expedited in-patient work-up:

          Risk Factor                                                                        Score

  • Age > or = 60                                                                      1
  • Blood Pressure (SBP > 140 and/or DBP > or = 90)                    1
  • Clinical Features (choose one)

          -- Unilateral weakness                                                           2

          -- Speech impairment w/o weakness                                       1

          -- Other                                                                               0       

  • Duration of Symptoms (minutes)

          -- > 60                                                                                2

          -- 10 to 59                                                                           1

          -- < 10                                                                                0

                                                                                              Total 0-6

 

 

Seven-day risk of stroke (stroke/no. of patients; %)

Point total

Possible TIA*

Probable or definite TIA

0 or 1

0/28 (0)

0/2 (0)

2

0/74 (0)

0/28 (0)

3

0/82 (0)

0/32 (0)

4

1/90 (1; 95% CI, 0 to 3)

1/46 (2; 95% CI, 0 to 6)

5

8/66 (12; 95% CI, 4 to 20)

8/49 (16; 95% CI, 6 to 27)

6

11/35 (31; 95% CI, 16 to 47)

11/31 (35; 95% CI, 19 to 52)

Total

20/375 (5.3; 95% CI, 3 to 7.5)

20/188 (10.6; 95% CI, 6 to 15)

Show References



Title: Stroke Associated with Aneurysm Coiling

Category: Neurology

Keywords: cerebral aneurysm, coiling, minimally invasive endovascular coiling, clipping, stroke, intracranial hemorrhage (PubMed Search)

Posted: 6/10/2009 by Aisha Liferidge, MD
Click here to contact Aisha Liferidge, MD

  • Patients who have recently undergone aneurysmal coiling commonly present to the ED with complaints of new or worsened focal neurologic deficits that may be suggestive of stroke.
  • Aneurysms can be stabilized by clipping or coiling them.  Coiling is performed in a minimally invasive manner, wherein platinum (a material that can be visualized radiographically and is flexible) coils are deployed into the bulb of the aneurysm, via femoral artery cannulation.
  • The relative risk of mortality or morbidity at one year post-coiling was found to be 22.6% less than that associated with clipping.  The latter is an older, more invasive technique requiring craniotomy and direct manipulation of the brain.
  • Hemorrhage is a less likely complication related to aneurysm coiling, thus your indication for a non-contrast Head CT in these patients would most appropriately be "rule out infarct" rather than "rule out bleed." 
  • Brain infarct is the more common complication of this treatment, and results from the accidental embolization of plaque during the coiling procedure.
  • Here are a couple of great links with illustrated overviews of the process of coiling, including a real time You Tube clip:

    http://www.brainaneurysm.com/aneurysm-treatment.html

    http://www.youtube.com/watch?v=Mvy8g_oDbbk